Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inka Seil

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|May 9, 2012
Predictive immunological markers in oncologyDirk Jäger, Inka Seil, Niels Halama
Cancer Immunity|December 13, 2005
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopesDirk Jäger, Julia Karbach, Claudia Pauligk, et al.
Gene|March 27, 2003
Phylogenetic relationships of non-mitochondrial nucleotide transport proteins in bacteria and eukaryotesNicole Linka, Herbert Hurka, B Franz Lang, et al.
International Journal of Cancer|March 3, 2007
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancerInka Seil, Claudia Frei, Holger Sültmann, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 1, 2007
NY-BR-1 is a differentiation antigen of the mammary glandDirk Jäger, Valeriy Filonenko, Ivan Gout, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 9, 2012
Predictive immunological markers in oncologyDirk Jäger, Inka Seil, Niels Halama
Cancer Immunity|December 13, 2005
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopesDirk Jäger, Julia Karbach, Claudia Pauligk, et al.
Gene|March 27, 2003
Phylogenetic relationships of non-mitochondrial nucleotide transport proteins in bacteria and eukaryotesNicole Linka, Herbert Hurka, B Franz Lang, et al.
International Journal of Cancer|March 3, 2007
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancerInka Seil, Claudia Frei, Holger Sültmann, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 1, 2007
NY-BR-1 is a differentiation antigen of the mammary glandDirk Jäger, Valeriy Filonenko, Ivan Gout, et al.
Pageof 1